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This is the second in a series of articles highlighting the delivery of
‘‘packages of care’’ for mental health disorders in low- and middle-
income countries. Packages of care are combinations of treatments aimed
at improving the recognition and management of conditions to achieve
optimal outcomes.
Introduction
Epilepsy is one of the most common and widespread
neurological disorders. Recent estimates suggest that it accounts
for 1% of the global burden of disease [1] and affects over 65
million people [2]. In addition, because the relatives and friends of
people with epilepsy (PWE) also bear the burden of this condition,
more than 500 million people are indirectly affected by epilepsy
[3]. Thus, epilepsy imposes a large economic burden on global
health care systems and is a major public health problem in low-
and middle-income countries (LMICs) [1].
The World Health Organization (WHO) estimates that 80% of
PWE live in LMICs. The incidence and prevalence of epilepsy are
thought to be higher in LMICs than in high-income countries
(HIC)—the median prevalence in LMICs is 9.5/1,000 compared
to 8/1,000 in Europe, although the prevalence varies widely
among countries [1,2]. The incidence of epilepsy in LMICs is
thought to be up to five times that in HICs, although there are
fewer studies on which to base this estimate. Worldwide, mortality
among PWE is two to three times higher than in the general
population and it is thought to be higher in LMICs than in HICs
although data are scarce [4]. The treatment gap, i.e., the
difference between the number of people with active epilepsy
and the number whose seizures are being appropriately treated, is
high in many LMICs [1]. Overall, 56% (range 7%–98%) of PWE
in LMICs remain untreated, with 73% remaining untreated in
rural regions compared to 46% in urban settings [5].
The International Classification of Disease (ICD) 10 diagnostic
criteria for epilepsy are given in Box 1 [6]. The definition of
epilepsy has recently been revised by the International League
Against Epilepsy (ILAE) [7], but the original classification of
seizures (transient occurrences of signs and/or symptoms due to
excessive or synchronous discharge of neuronal activity in the
brain) as partial (focal), generalized, or unclassified remains useful
[8]. Epilepsy has many different etiologies, with head trauma,
central nervous system infections, perinatal problems, and
cerebrovascular accidents most commonly identified [1], although
in most cases a cause is not found. Focal epilepsies represent a
greater proportion of epilepsies in LMICs than in HICs and risk
factor analysis has identified many causes that are preventable.
Although seizures are its most overt manifestations, epilepsy is
associated with significant psychological [9] and psychiatric
conditions [10], which have social consequences for everyday
living [11]. Psychiatric disorders occur in 25%–30% of PWE [10],
with depression being the most common, followed by anxiety
disorders, psychoses, and personality disorders [12,13]. Psychiatric
comorbidity appears to be particularly common in some LMICs
[14]. Stigma poses a major burden to PWE and their families,
interfering with the opportunities that PWE have for employment
and marriage [15]. Finally, women with epilepsy are particularly
vulnerable to sexual exploitation, physical abuse, and extreme
poverty [16].
In this article, we focus on the management of epilepsy in
LMICs. We review the evidence from LMICs on the efficacy of
treatments and delivery of interventions. Because that evidence is
often limited, we also refer to systematic reviews, meta-analyses,
and key trials from HICs where appropriate. On the basis of this
review, we propose a package of care—a combination of
interventions aimed at improving the recognition and manage-
ment of conditions to achieve optimal outcomes—for epilepsy.
The Evidence on the Treatment of Epilepsy
The evidence for most aspects of the management of epilepsy is
poor in both high- and low-income settings (Table 1).
Detection of Epilepsy
Much epilepsy in the world is not identified, particularly in
LMICs, and thus PWE may not benefit from treatment. The
diagnosis of epilepsy is based on clinical history alone, but since
patients may become unconsciousness during seizures, an
independent observer is often necessary. In HICs misdiagnosis
occurs in 5%–30% of cases [17], and in LMICs this is likely to be
higher. In HICs, clinical examination may identify the cause of
epilepsy and help with prognosis [18]. For example, electroen-
cephalography (EEG) may detect epileptic discharges, which
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support the diagnosis, but is not necessary for confirmation.
Although this test lacks sensitivity and specificity [17], it is useful
for classification of seizures and epilepsy syndromes. Video
electroencephalography (telemetry) is particularly useful for
management of intractable epilepsy. Various biochemical tests
can help in differential diagnosis and can determine an underlying
cause of epilepsy. Computerized tomography (CT) scanning is
useful for demonstrating gross abnormalities, haemorrhages, and
calcification and for detecting parasitic diseases, e.g., neurocysti-
cercosis [19]. Magnetic resonance imaging (MRI) is more sensitive
than tomography in identifying structural abnormalities [20]. It is
recommended that patients with refractory epilepsy undergo
functional neuroimaging. Finally, single-photon emission comput-
er tomography and positron emission tomography may help locate
ictal foci, and are particularly useful in identifying candidates for
surgery [21]. Unfortunately, these investigations are rarely
available in LMICs.
Anti-epileptic Drug Therapy
Because the cause of epilepsy is often undetermined, and in
most cases the epileptogenic focus cannot be removed, anti-
epileptic drugs (AEDs) are used to control seizures. In HICs, AEDs
may be considered if the person has had seizures within the past
2–5 y (active epilepsy), but in many LMICs AEDs are only often
recommended in PWE with a seizure in the past year. AEDs are
very effective in controlling seizures: 75% of those treated may
become seizure free; 20%–30% of PWE have spontaneous
remission of seizures without treatment [22]. Phenobarbital is
the least expensive and most widely used AED. It controls a range
of seizure types and is on the essential drug list of 95% countries
surveyed by the WHO; phenytoin, carbamazepine, and valproate
(also first-line AEDs) are on the essential drug list in 86%, 93%,
and 87% of countries, respectively [1]. Many other AEDs have
been introduced to HICs but are not widely available in LMICs.
Each of these AEDs has a profile of adverse events, which may
influence their use.
Few randomized trials have compared the efficacy and
effectiveness of these first-line AEDs, and most of these trials
were conducted in HICs. In a recent review by the International
League Against Epilepsy (ILAE), evidence for the efficacy and
effectiveness of AEDs as initial monotherapy was found only in
adults with partial-onset seizures (carbamazepine, phenytoin, and
valproate), children with partial-onset seizures (oxcarbazepine),
and elderly adults with partial-onset seizures (gabapentin and
lamotrigine) [23]. In Cochrane reviews, no significant differences
were documented in efficacy between phenobarbital, carbamaz-
epine, phenytoin, or valproate in patients with generalized or
Summary Points
N Epilepsy is the most common chronic neurological
disorder, affecting over 65 million people worldwide, of
whom 80% are estimated to live in low- or middle-
income countries (LMICs).
N Anti-epileptic drugs are very effective in controlling
seizures, but most people with epilepsy in LMICs do not
receive appropriate treatment.
N This ‘‘treatment gap’’ is influenced by factors such as
limited knowledge, poverty, cultural beliefs, stigma, poor
health delivery infrastructure, and shortage of trained
health care workers.
N Several studies implementing interventions at the
community level (for example, training programs for
primary health care workers) have successfully improved
the identification of people with epilepsy and reduced
the treatment gap.
N The sustainability of these interventions needs to be
addressed, however, and efforts must be made to ensure
a continuous supply of anti-epileptic drugs.
Box 1. International Classification of Diseases
10 Criteria for Epilepsy [6]
‘‘G40.0 Localization-related (focal or partial) idio-
pathic epilepsy and epileptic syndromes with
seizures of localized onset
Benign childhood epilepsy with centrotemporal EEG spikes
Childhood epilepsy with occipital EEG paroxysms
G40.1 Localization-related (focal or partial) symp-
tomatic epilepsy and epileptic syndromes with
simple partial seizures
Attacks without alteration of consciousness
Simple partial seizures developing into secondarily gener-
alized seizures
G40.2 Localization-related (focal or partial) symp-
tomatic epilepsy and epileptic syndromes with
complex partial seizures
Attacks with alteration of consciousness, often with
automatisms
Complex partial seizures developing into secondarily
generalized seizures
G40.3 Generalized idiopathic epilepsy and epileptic
syndromes
Benign:
Myoclonic epilepsy in infancy
Neonatal convulsions (familial)
Childhood absence epilepsy
Epilepsy with grand mal seizures on awakening
Juvenile:
Absence epilepsy
Myoclonic epilepsy [impulsive petit mal]
Nonspecific epileptic seizures:
Atonic
Clonic
Myoclonic
Tonic
Tonic-clonic
G40.4 Other generalized epilepsy and epileptic
syndromes
Epilepsy with:
Myoclonic absences
Myoclonic-astatic seizures
Infantile spasms
Lennox-Gastaut syndrome
Salaam attacks
Symptomatic early myoclonic encephalopathy
West’s syndrome
G40.5 Special epileptic syndromes
Epilepsia partialis continua
Epileptic seizures related to: alcohol, drugs, hormonal
changes, sleep deprivation or stress
G40.6 Grand mal seizures, unspecified (with or
without petit mal)
G40.7 Petit mal, unspecified, without grand mal
seizures
G40.8 Other epilepsy
Epilepsies and epileptic syndromes undetermined as to
whether they are focal or generalized
G40.9 Epilepsy, unspecified’’
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partial-onset seizures [24–27]. In LMICs, carbamazepine was not
shown to be better than phenobarbital in Ecuadorian [28] or
Kenyan adults [29]. In Indian children, there was no difference in
efficacy between phenobarbital and phenytoin [30]. However,
questions have been raised about the suitability of phenobarbital
because of its adverse events [31], and the ILAE has argued that
the status of this drug is based on economic factors, rather than on
efficacy and suitability [32].
Surgery
Surgical removal of the epileptic focus is the only cure for
epilepsy. Palliative procedures can also be performed. Surgery
requires a thorough evaluation to identify the epileptic focus and the
relationship of this focus to other functionally important areas of the
brain (for example, the speech centre). A recent meta-analysis
identified factors associated with seizure remission following surgery
(Table 1) [33]. Because surgery requires sophisticated facilities and
specialized staff, it is usually only available in HICs. Nevertheless,
surgery is increasingly being performed in LMICs [34].
Vagus Nerve Stimulation
This technique is proposed for the treatment of refractory
epilepsy and for the treatment of PWE who are not candidates for
surgical treatment. It is effective in treatment of epilepsy patients
with partial seizures [35], but is not widely available in LMICs.
Lifestyle Changes
Although seizures cannot be prevented by lifestyle changes
alone, PWE can nevertheless make changes that improve their
lives and give them a sense of control. For example, although
many PWE do not know the precipitants for their seizures,
inadequate sleep, food allergies, alcohol, smoking, and flashing
lights may trigger seizures in some patients and can be avoided.
Similarly, exercise is important for many aspects of epilepsy [36],
particularly to counteract the side effects of some AEDs. However,
exercise can trigger seizures in some patients. Finally, dietary
changes may prevent the adverse events of some AEDs—
phenytoin interferes with vitamin D metabolism, for example.
The ketogenic diet (high-fat, no-sugar, low protein diet) is
indicated in specific epilepsy syndromes [37], but requires
specialized nutritional support that is often not available in
LMICs [38]. Other diets are unproven.
Psychosocial Therapy
Psychological interventions such as psychotherapy, individual,
group, or family counseling, progressive relaxation therapy, and
cognitive behaviour therapy have all been used in epilepsy (Table 1).
However, the trials were small and were mainly conducted in HICs
and a systematic review concluded that there was no reliable
evidence to support the use of these treatments [39].
Delivery of Effective Interventions
Delivery of efficacious interventions in LMICs can only be
achieved if PWE are correctly identified. Unfortunately, the
symptoms of some types of epilepsy (for example, hallucinations)
may not be recognized as part of an illness, particularly in LMICs
where epilepsy is interpreted within traditional belief systems.
Furthermore, in LMICs, trained personnel for the detection and
management of epilepsy and facilities for investigations of
underlying causes are scarce [1]. However, nurses, community
health workers, and key informants such as teachers can improve
the identification of PWE [29,40], and these PWE can then benefit
from various interventions (Table 2).
Interventions to Ensure an Adequate Drug Supply
One of the factors contributing to the treatment gap in epilepsy
in LMICs is the lack of a continuous and affordable supply of
AEDs [31,32]. Phenobarbital is most widely used in LMICs.
Other available AEDs such as phenytoin, carbamazepine, and
valproate are three, 11, and 16 times more expensive, respectively,
than phenobarbital [1]; and are often not available and/or
routinely prescribed in peripheral health facilities. Because only a
Table 1. The evidence in support of epilepsy treatment.
Epilepsy Management HICs LMICs
Detection and diagnosis Screening questionnaires [58,59]; Use of medical records [60,61]; Neurological
examination [18]; EEG [17]; MRI, CT scan [19–21]
Screening questionnaires [29,62,63]; EEG
[64]; CT scan [65]; MRI scan in those with
abnormal EEG [66]
AEDs Systematic review of initial monotherapy in adults with partial-onset seizures
(carbamazepine, phenytoin, and valproic acid), children with partial-onset
seizures (oxcarbazepine), and elderly adults with partial-onset seizures
(gabapentin and lamotrigine) [23]. Cochrane reviews of efficacy and withdrawal
rates associated with phenobarbital, carbamazepine, phenytoin, or sodium
valproate use in patients with generalized or partial onset seizures [24–27].
RCTs of carbamazepine and
phenobarbital in Ecuadorian [28] and
Kenyan adults [29] and in Indian [30] and
Bangladeshi children [67]. Observational
studies of phenobarbital in China [68],
and phenobarbital and phenytoin in India
[30,41].
Surgery Meta-analysis to identify prognostic indicators of seizure remission after
surgery [33].
Overview of more than 1,000 operations
for epilepsy in India [69].
Ketogenic diet Systematic review of trials of the ketogenic diet [37]. RCT of the ketogenic diet
in children with AED-resistant epilepsy [70].
Ketogenic diet [38]
Psychosocial and psychoeducational
interventions
RCT of a 2-d psychoeducational treatment program [71]. RCT of a 6-wk
structured psychoeducational group intervention for adolescents with epilepsy
and their parents [72]. RCT of a structured nurse-led intervention [73].
Nonrandomized intervention study that
provided leaflets about drug information
to Taiwanese adults with epilepsy [74].
Cognitive behaviour therapy — RCT of acceptance and commitment
therapy in South Africa [75].
Relaxation therapy Two-phase experimental group investigation of a contingent relaxation
treatment program [76].
—
Abbreviations: RCT, randomized controlled trial.
doi:10.1371/journal.pmed.1000162.t001
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1–3-mo supply of AEDs is dispensed at any one time, PWE have
to attend clinics frequently and the cost of these visits may
interrupt adherence. Furthermore, the systems for providing a
continuous supply of AEDs, particularly to rural clinics, often fail,
which discourages attendance. Studies in Kenya and India have
shown that programs that ensure a continuous supply of AEDs can
improve adherence [29,41], thereby reducing the treatment gap.
Drug banks set up by nongovernmental organizations (NGOs) in
some LMICs to supply hospitals when there is a shortage within
the government sector can help to ensure adequate drug supplies
but are difficult to sustain.
Interventions to Educate PWE and Caregivers about
Epilepsy
Education of PWE and caregivers about epilepsy is important for
several reasons. First, PWE with limited knowledge of epilepsy are at
increased risk of the complications of seizures, such as fractures,
burns, and accidental death [42,43]. Second, one of the major
conflicts in LMICs is the community’s beliefs of the cause of epilepsy,
and thus its treatment. In many societies, epilepsy is not thought to be
caused by diseases of the brain, but is attributed to traditional beliefs
such as spirits [44]. Finally, in LMICs, PWE often have cognitive
impairment and psychiatric comorbidity, which impairs their
understanding of epilepsy and the need to take AEDs daily. Thus,
the care of PWE often falls onto family members and friends.
Although psychoeducational interventions tested in randomized
controlled trials in HICs significantly improved knowledge and
coping with epilepsy and decreased seizure frequency in HICs
(Table 1), there have been no similar trials in LMICs, and the
educational interventions required are likely to be different in
these settings. There have been some programs that increased the
knowledge of epilepsy in LMICs as part of a package of
interventions but the components of these programs with the
most significant effect on AED adherence, seizure outcome, and
self-esteem among PWE are difficult to identify [45–47].
Patient support groups are found in many countries and play an
important role in educating PWE and their caregivers, as well as in
advocacy (http://www.ibe-epilepsy.org/links). In addition to
education, PWE and their families may also benefit from targeted
psychosocial interventions. For example, a study in a London out-
patient clinic provided evidence that the provision of skilled
counseling to patients with epilepsy in addition to ‘‘routine’’
therapeutic intervention is useful [48]. Counseling helps to deal
with many of the problems associated with epilepsy that are not
related to the medical or technical aspects of seizure control.
Unfortunately, the resources needed for counseling PWE and their
caregivers are often not available in LMICs and the provision of
such services competes with other health needs.
Community-Based Interventions to Improve Awareness
Public education is generally advocated as the best method to
reduce the stigma attached to conditions such as epilepsy, but
interventions need to be based upon qualitative and quantitative
assessments to identify the causes of stigma in each region [15].
Information, education, communication, and social marketing are
needed to enhance compassion and reduce blame [49]. Community
programs to achieve these aims must be based on the local
perceptions of epilepsy and needs and must consider social and
cultural conditions in the region. To date, community programs
have met with some success in Kenya [29], Ecuador [28], Malawi
[50], Ethiopia [51], and India [41]. Community-based studies in
Kenya and India that supplied free AEDs reported low rates of
withdrawal and good adherence and response to therapy [29,41]. In
Ethiopia, community awareness and a regular supply of phenobar-
bital increased the number of patients attending the clinic [51]. In
Malawi, the model tested included publicity of accessible services,
adequate supplies of AEDs, setting up of mobile clinics, and
frequent follow up by health workers [50]. Unfortunately, most of
these programs do not appear to have been sustained since they
relied on external funds. Thus, epilepsy care needs to be integrated
Table 2. Delivering epilepsy treatments.
Step How By Whom In What Settings
Increasing demand for the
package
Advocacy campaign with the message: ‘‘Epilepsy can
be controlled’’ [1,52]
Patients and support groups; Community
health workers; Nurses and physicians;
Traditional healers; Public health personnel
[29,41,45,46,77,78]
Community meetings; Schools;
Media, e.g., radio, newspapers;
General practice; Homesteads
Increasing access to the
package
Making AEDs available in health facilities [29,41,51];
Improving awareness about the access to AEDs in
health facilities [29,46,51]; Organizing satellite clinics
[46,50]; Collaborating with other stakeholders in the
health sector [79,80]
Ministries of Health [1,31]; NGOs [79,80];
Private and voluntary agencies
Primary health centres; Private
clinics; Hospitals
Improving recognition
of the disorder
Community-based and practice-based screening to
identify the patients and causes; Clinical history;
Neurological examination; Examination of blood AED
levels and parasitic infections [1]
Health care workers [29,41,46,51]; Research
assistants; Technicians [45]
Community; Primary health
centres; Maternal and child
health clinics; District General
Hospitals; Referral hospitals
Initiation of evidence-based
treatments
Supply of first-line AEDs [29,30,41,68]; Training on
principles of AED use
Health care workers with license to
prescribe AEDs
Primary health centres; Private
clinics; Hospitals
Managing serious or complex
cases
Referral to other centres with specialist resources [46] Specialist health care workers Centres with medical staff with
expertise in epilepsy
Achieving optimal outcomes Increasing AED adherence to reduce seizures, e.g.,
adherence management until full control achieved
for at least 2 y [29,45]
Health care workers [45] Primary health centres; Private
clinics; Hospitals; Homesteads
Addressing impacts on other
health/social outcomes
Improving quality of life by, for example, psychosocial
counseling of the family and PWE [48,81]; Reducing
stigma [15,50]
Health care workers [45,77]; Traditional
healers [55,56]; Psychiatrists [46];
Psychologists [47]
Primary health centres; Private
clinics; Hospitals; Homesteads;
Counseling centres
doi:10.1371/journal.pmed.1000162.t002
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into primary health care delivery, perhaps with patients providing
some of the cost of AEDs to enhance sustainability [45].
The Global Campaign Against Epilepsy, a partnership between
the WHO, ILAE, and the International Bureau for Epilepsy was
launched in 1997 to improve the acceptability, treatment, services,
and prevention of epilepsy worldwide [52]. Several demonstration
projects are currently underway under the auspices of this Campaign
that aim to reduce the treatment gap and the physical and social
burden of epilepsy through community-level interventions. The most
successful is the Chinese project, which started with a media-based
education program to create awareness about epilepsy and to convey
the message that epilepsy is treatable. The program provided free
phenobarbital at local health centres and patients were followed up
by primary health care physicians who had received basic training in
the diagnosis and management of epilepsy [53]. Lectures and group
discussions for PWE and their families were arranged and community
leaders and teachers were given information about epilepsy. This
project improved adherence to AEDs and significantly decreased the
treatment gap from 63% to 50% [53].
Interventions to Train Health Care Providers
There are few specialists, particularly neurologists, in LMICs [1]
and health care providers are often ignorant about epilepsies,
particularly about their causes, diagnosis, treatment, and psycho-
social aspects. Interventions to train health care workers should,
therefore, equip them with the knowledge and skills needed to
diagnose and manage epilepsy, to counsel PWE, and to make
appropriate referrals. It should promote strategies to ensure
adherence and follow-up care [46]. Training facilities often cannot
be established in LMICs because of the expense [1]. Thus, the
training of health care providers in such countries requires the
production and distribution of educational materials, including
standard guidelines for diagnosis and care of PWE. Our review
indicates that educational interventions that targeted health care
providers in Zimbabwe and Ethiopia greatly improved the
diagnosis and management of epilepsy [45,51].
Interventions to Involve Traditional Healers
Despite important advances in the understanding and treatment
of epilepsy, many communities in LMICs still believe that epilepsy
is supernatural or sacred and is associated with possession,
impurity, contagion, heredity, and madness. In many parts of
Africa and Asia, notions about epilepsy are rooted not in a medical
model but in a spiritual model [54]. Often these beliefs involve
external factors and so PWE seek a contextually relevant cure from
a traditional healer that removes the alien factor from the body
rather than seeking preventative or biomedical treatment.
Traditional healers live within the community and know the
communities’ perceptions of ill health. Their concentration is
much higher in many populations than medical staff [55], and
they provide explanations that members of the community believe.
They can also provide psychosomatic support, spend longer with
their clients than medical staff, and will accept flexible payment
systems [56]. But as a group of health care providers, their
training, expertise, and beliefs are very variable, and their activities
rarely regulated. Nevertheless, because they are frequently
consulted in many LMICs, involving traditional healers in the
management of epilepsy might be a useful intervention.
Interventions to Integrate Epilepsy Care into Existing
Health Services
Acceptance of epilepsy treatment may be markedly improved by
integrating it into existing health care services. Mental health
services are particularly important in LMICs since there are more
psychiatrists than neurologists and PWE often have considerable
psychiatric comorbidity. Experience in both Kenya and Malawi
has shown that although epilepsy care can be successfully provided
in LMICs, it is much harder to sustain it when it is not integrated
into such services [29,50]. Programs that address epilepsy alone
are unlikely to be sustained, and there is a compelling argument
that such programs should be incorporated into mental illness or
chronic disease services. The sustainability of these programs
depends on community participation in planning, implementation,
and evaluation as well as integration into primary health care [31].
A study conducted in Ethiopia illustrated how an existing health
care infrastructure developed for treatment of infectious diseases
could be adapted to deal with epilepsy [51]. An Indian study
showed that management of epilepsy should be set within the
context of rehabilitation and incorporated into wider programs
aimed at the alleviation of poverty [57]. In addition, a
commitment needs to be made to deal with the many preventable
causes of epilepsy in LMICs such as poor perinatal care, head
trauma, and parasitic infections, by integrating epilepsy into wider
public health programs [31].
Epilepsy services could also be improved in the community
through approaches such as ‘‘extension services’’ (satellite clinic
model) of apex institutions and collaboration with other organi-
zations (Table 2). Satellite clinics facilitate the provision of services
to the neglected populations of rural areas by reducing the
distances travelled by PWE to attend health facilities. Similarly,
the creation of partnerships between governmental, private, and
voluntary agencies, has proved a useful, cost-effective, and
sustainable way to improve the identification and management
of PWE [41,46]. More specifically, in two studies in India where
workers in NGOs that were already involved in community-based
health care received training in case ascertainment and in
informing communities about epilepsy, the epilepsy service
continued after the studies ended because it was integrated into
existing health care provision [41,57].
Packages of Care for Epilepsy in LMICs
Epilepsy, one of the most common neurological conditions, is
under-resourced and undertreated in LMICs. A large number of
people have significant morbidity and mortality because of the
failure to identify cases, difficulties with infrastructure, and the
unavailability of suitable AEDs. Education of the community and
of health care workers will improve the identification of PWE and
thus reduce the treatment gap, provided inexpensive and reliable
supplies of AEDs are available. Governments in LMICs need to
recognize the burden of epilepsy and need to develop packages of
care to reduce the disability associated with this condition in an
efficient, sustainable, and equitable manner. We propose two
packages of care based on the availability of resources (Table 3).
Ideally, the delivery of these packages should be integrated into
existing primary health care with the help of NGOs and other
nonmedical staff involved in community-based and mental health
care.
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